Weekly Recap | 361 DEGREES -3.19%, consensus target 46% above spotWeekly Review·Nov 14, 2026 at 05:06 AM01361-0.31%
LQIDA's AI Edge Push Drives Hong Kong Small-Cap M&A Surge into Tech, BiotechGlobal Report·Oct 28, 2026 at 09:21 AM01361-0.31%008530.00%
Hong Kong's Consumer Divide: Vitasoy Stumbles as 361 Degrees and Pharma OutperformGlobal Report·Oct 22, 2026 at 09:14 AM00345-1.73%01361-0.31%
Guotai Haitong Keeps Their Buy Rating on 361 Degrees International (TSIOF)Tip Ranks·Oct 18, 2026 at 05:15 AM01361-0.31%
Weekly Recap | 361 DEGREES +7.34%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 05:25 AM01361-0.31%
361 Degrees International (TSIOF) Receives a Buy from CICCTip Ranks·Oct 16, 2026 at 05:05 AM01361-0.31%
361 DEGREES 3Q Main Brand Retail Sales Post Mid-single-digit YoY GrowthAASTOCKS News·Oct 14, 2026 at 02:10 AM01361-0.31%
361 Degrees Posts Steady Q3 2026 Sales Growth and Clarifies Share Option CapacityTip Ranks·Oct 14, 2026 at 12:07 AM01361-0.31%
Hong Kong's Small Caps Split on Buybacks, Medicare Policy and GoldGlobal Report·Oct 6, 2026 at 10:48 AM01415-3.01%02697-5.86%
Hong Kong Mid-Caps Divide: JNBY's Marsèll Deal Shines Amid Pharma SlumpGlobal Report·Oct 6, 2026 at 09:16 AM00147-9.15%01617-1.90%
Small-Cap Divergence in Hong Kong: JiaYue Health Jumps 118% on Turnaround, Buybacks Signal ConfidenceGlobal Report·Sep 30, 2026 at 10:14 AM01023+1.33%08193+1.11%
Hong Kong Niche Players Signal Strategic Pivots Amid Macro ShiftsGlobal Report·Sep 23, 2026 at 10:12 AM009900.00%01119+1.67%
Hong Kong Non-Core Equities Diverge: 361 Degrees Tops Estimates While Jiumaojiu StrugglesGlobal Report·Sep 8, 2026 at 11:33 AM01361-0.31%02453+1.75%
Tech and Niche Equipment Makers Reshape Hong Kong's Alternative Stock LandscapeGlobal Report·Sep 8, 2026 at 10:20 AM06031+0.38%01850-1.49%